Five-year follow-up of the sirolimus-eluting stents vs vascular brachytherapy for bare metal in-stent restenosis (SISR) trial

American Heart Journal

Volumn 163, Issue 3, 2012, Pages 438-445

  Alli, Oluseun O ^a   Teirstein, Paul S ^b   Satler, Lowell ^c   Sketch, Michael H ^d   Popma, Jeffery J ^e   Mauri, Laura ^f   Wang, Hong ^g   Schleckser, Patricia A ^h   Cohen, Sidney A ^g   Holmes, David R ^a  

^a MAYO CLINIC   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; ARTICLE; BARE METAL STENT; BRACHYTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; STENT THROMBOSIS; SURVIVAL RATE; TREATMENT FAILURE; VASCULAR BRACHYTHERAPY;

EID: 84863337545     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.11.019     Document Type: Article

References (27)

1. P.S. Teirstein, C.A. Hoover, and R.W. Ligon Repeat coronary angioplasty: efficacy of a third angioplasty for a second restenosis J Am Coll Cardiol 13 1989 291 296
2. B. Meier, S.B. King III, and A.R. Gruentzig Repeat coronary angioplasty J Am Coll Cardiol 4 1984 463 466
3. D.O. Williams, A.R. Gruentzig, and K.M. Kent Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis Am J Cardiol 53 1984 32C 35C
4. R. Mehran, G.S. Mintz, and J.J. Popma Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis Am J Cardiol 78 1996 618 622
5. S.G. Lee, C.W. Lee, and S.S. Cheong Immediate and long-term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in-stent restenosis Am J Cardiol 82 1998 140 143
6. S.K. Sharma, S. Duvvuri, and G. Dangas Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases J Am Coll Cardiol 32 1998 1358 1365
7. P.S. Teirstein, V. Massullo, and S. Jani Catheter-based radiotherapy to inhibit restenosis after coronary stenting N Engl J Med 336 1997 1697 1703
8. P.S. Teirstein, V. Massullo, and S. Jani Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial Circulation 101 2000 360 365
9. M.B. Leon, P.S. Teirstein, and J.W. Moses Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 2001 250 256
10. J.J. Popma, M. Suntharalingam, and A.J. Lansky Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis Circulation 106 2002 1090 1096
11. R. Waksman, A.E. Ajani, and R.L. White Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation 109 2004 340 344
12. D.R. Holmes Jr., P. Teirstein, and L. Satler Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial JAMA 295 2006 1264 1273
13. G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
14. A. Dibra, A. Kastrati, and F. Alfonso Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J Am Coll Cardiol 49 2007 616 623
15. D.R. Holmes Jr., P.S. Teirstein, and L. Satler 3-Year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial JACC 1 2008 439 448
16. S.G. Ellis, C.D. O'Shaughnessy, and S.L. Martin Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial Eur Heart J 29 2008 1625 1634
17. Mauri L, Kereiakes DJ, Normand SL, et al. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J;160:1035-41, 1041 e1.
18. Barker CM, Murray SS, Teirstein PS, et al. Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity. Jacc;3:1001-7.
19. A.J. Carter, M. Aggarwal, and G.A. Kopia Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovas Res 63 2004 617 624
20. D.W. Park, M.K. Hong, and G.S. Mintz Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study J Am Coll Cardiol 48 2006 2432 2439
21. J. Cosgrave, S.J. Corbett, and G. Melzi Late restenosis following sirolimus-eluting stent implantation Am J Cardiol 100 2007 41 44
22. F. Feres, J. Munoz, and A. Abizaid Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis J Invasive Cardiol 17 2005 473 477
23. F. Liistro, G. Stankovic, and C. Di Mario First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome Circulation 105 2002 1883 1886
24. Nakagawa Y, Kimura T, Morimoto T, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol;106:329-36.
25. Kuriyama N, Kobayashi Y, Nakama T, et al. Late restenosis following sirolimus-eluting stent implantation. Jacc;4:123-8.
26. R. Prpic, P.S. Teirstein, and J.P. Reilly Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis Circulation 106 2002 2340 2345
27. A. Caixeta, M.B. Leon, and A.J. Lansky 5-Year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents J Am Coll Cardiol 54 2009 894 902